The number of patients accessing Denmark’s medical cannabis pilot program nearly halved in the third quarter of 2019, largely because of supply interruptions related to Canadian producer CannTrust’s regulatory misconduct. Reports MJ Biz
Unique consumers fell to 582 in the July-September period from 1,045 in the April-June quarter, according to Danish Health Authority data published last week.
The decline was largely expected, said Rikke Jakobsen, CEO of nongovernmental organization Cannabis Denmark.
Read full story at